Stock Report

All about this stock under one free report Last Updated: 26-Oct-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Genmab A/S ADS - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$43.79

up-down-arrow $3.79 (9.48%)

As on 23-Oct-2026 16:17EDT

Market cap

info icon

$26,927 Mln

Revenue (TTM)

info icon

$4,131 Mln

P/E Ratio

info icon

31.5

P/B Ratio

info icon

3.6

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 28.43 24.89 -68.25 -36.62 -10.81
EBIT 117.74 -6.23 -75.80 -46.94 -22.58
Net Profit 469.59 -9.80 -85.61 -44.62 -20.70
EPS 489.39 -9.39 -85.16 -43.56 -19.77
Book Value -- -- -84.84 -40.56 -21.41
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info 37.2641.3328.4434.0143.13
Net Margin info ----19.08----
Return on equity info 14.0915.7313.374.5322.97
Return on Capital info 13.5915.28--3.9322.38
Return on Assets info 11.9813.767.603.2919.34
Debt to Equity (x) info ----0.810.930.03

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
--
3.93
22.38
14.44
21.59
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

13.37

Higher than Peers by 31.15

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
13.37
4.53
22.97
14.78
22.04
Peer Median
-17.79
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

7.60

Higher than Peers by 20.08

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
7.60
3.29
19.34
13.31
19.92
Peer Median
-12.48
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

28.44

Higher than Peers by 81.64

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
28.44
34.01
43.13
34.64
48.15
Peer Median
-53.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

19.08

Higher than Peers by 79.33

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
19.08
25.89
36.44
26.42
37.59
Peer Median
-60.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-68.25

Lower than Peers by 90.43

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
-68.25
-0.83
0.31
0.14
0.72
Peer Median
22.18
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-75.80

Lower than Peers by 88.48

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
-75.80
-86.36
62.68
-18.28
77.66
Peer Median
12.68
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-85.61

Lower than Peers by 96.52

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
-85.61
-87.71
80.24
-20.18
84.38
Peer Median
10.91
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-85.16

Lower than Peers by 114.07

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
-85.16
-0.88
0.85
-0.20
0.85
Peer Median
28.92
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

12.89

Higher than Peers by 11.49

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
12.89
--
--
--
--
Peer Median
1.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.81

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
0.81
0.93
0.03
0.02
0.02
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.05

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
0.05
0.05
0.00
0.00
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

2.46

Lower than Peers by 2.19

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
2.46
2.02
5.25
13.34
15.48
Peer Median
4.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.44

Lower than Peers by 2.21

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
2.44
2.01
5.24
13.32
15.56
Peer Median
4.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

4.36

Higher than Peers by 3.66

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
4.36
20.74
77.37
211.37
332.57
Peer Median
0.71
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

30.98

Higher than Peers by 5.80

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
30.98
30.87
31.08
30.03
39.38
Peer Median
25.19
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.40

Higher than Peers by 0.14

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
0.40
0.13
0.53
0.50
0.53
Peer Median
0.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
--
384.60
98.74
118.16
114.31
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
--
47.22
22.06
-69.49
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
--
1,259.72
855.46
3,250.89
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
--
-827.90
-734.66
-3,202.22
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

31.50

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
31.50
21.49
1.71
4.81
5.14
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

3.55

Lower than Peers by 0.10

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
3.55
3.55
0.36
0.66
1.03
Peer Median
3.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

19.51

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
19.51
18.27
-0.69
-1.07
0.85
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

26,927

Higher than Peers by 26,804

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Genmab A/S ADS - ADR
26,927
--
--
--
--
Peer Median
122
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...